Clinical trial
Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With…
NCT00398385 · National Cancer Center, Korea, Other · Unknown status
Key facts
| NCT number | NCT00398385 |
|---|---|
| Title | Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer |
| Official title | A Randomized Phase II Study of Preoperative Versus Postoperative Gemcitabine and Cisplatin for Patients With Stage IB-II Non-Small Cell Lung Cancer |
| Lead sponsor | National Cancer Center, Korea, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, gemcitabine hydrochloride, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 170 |
| Start date | May 1, 2005 |
| Primary completion | Apr 1, 2010 |
| First posted | Nov 10, 2006 |
| Last update posted | Aug 12, 2013 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: